Cargando…

Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty

PURPOSE: For the implementation of personalised surveillance, it is important to create more awareness among HCPs with regard to the risk for locoregional recurrences (LRRs). The aim of this study is to evaluate the current awareness and estimations of individual risks for LRRs after completion of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankersmid, Jet W., Spronk, Pauline E. R., Zeillemaker, Anneke M., Siesling, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090881/
https://www.ncbi.nlm.nih.gov/pubmed/35279762
http://dx.doi.org/10.1007/s10549-022-06549-9
_version_ 1784704820377026560
author Ankersmid, Jet W.
Spronk, Pauline E. R.
Zeillemaker, Anneke M.
Siesling, Sabine
author_facet Ankersmid, Jet W.
Spronk, Pauline E. R.
Zeillemaker, Anneke M.
Siesling, Sabine
author_sort Ankersmid, Jet W.
collection PubMed
description PURPOSE: For the implementation of personalised surveillance, it is important to create more awareness among HCPs with regard to the risk for locoregional recurrences (LRRs). The aim of this study is to evaluate the current awareness and estimations of individual risks for LRRs after completion of primary treatment for breast cancer among health care professionals (HCPs) in the Netherlands, without using any prediction tools. METHODS: A cross-sectional survey was performed among 60 HCPs working in breast cancer care in seven Dutch hospitals and 25 general practitioners (GPs). The survey consisted of eleven realistic surgically treated breast cancer cases. HCPs were asked to estimate the 5-year risk for LRRs for each case, which was compared to the estimations by the INFLUENCE-nomogram using one-sample Wilcoxon tests. Differences in estimations between HCPs with different specialities were determined using Kruskal–Wallis tests and Dunn tests. RESULTS: HCPs tended to structurally overestimate the 5-year risk for LRR on each case. Average overestimations ranged from 4.8 to 26.1%. Groups of HCPs with varying specialities differed significantly in risk estimations. GPs tended to overestimate the risk for LRRs on average the most (15.0%) and medical oncologists had the lowest average overestimation (2.7%). CONCLUSIONS: It is important to create more awareness of the risk for LRRs, which is a pre-requisite for the implementation of personalised surveillance after breast cancer. Besides education for HCPs, the use of prediction models such as the INFLUENCE-nomogram can support in estimating an objective estimate of each individual patient’s risk.
format Online
Article
Text
id pubmed-9090881
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-90908812022-05-12 Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty Ankersmid, Jet W. Spronk, Pauline E. R. Zeillemaker, Anneke M. Siesling, Sabine Breast Cancer Res Treat Preclinical Study PURPOSE: For the implementation of personalised surveillance, it is important to create more awareness among HCPs with regard to the risk for locoregional recurrences (LRRs). The aim of this study is to evaluate the current awareness and estimations of individual risks for LRRs after completion of primary treatment for breast cancer among health care professionals (HCPs) in the Netherlands, without using any prediction tools. METHODS: A cross-sectional survey was performed among 60 HCPs working in breast cancer care in seven Dutch hospitals and 25 general practitioners (GPs). The survey consisted of eleven realistic surgically treated breast cancer cases. HCPs were asked to estimate the 5-year risk for LRRs for each case, which was compared to the estimations by the INFLUENCE-nomogram using one-sample Wilcoxon tests. Differences in estimations between HCPs with different specialities were determined using Kruskal–Wallis tests and Dunn tests. RESULTS: HCPs tended to structurally overestimate the 5-year risk for LRR on each case. Average overestimations ranged from 4.8 to 26.1%. Groups of HCPs with varying specialities differed significantly in risk estimations. GPs tended to overestimate the risk for LRRs on average the most (15.0%) and medical oncologists had the lowest average overestimation (2.7%). CONCLUSIONS: It is important to create more awareness of the risk for LRRs, which is a pre-requisite for the implementation of personalised surveillance after breast cancer. Besides education for HCPs, the use of prediction models such as the INFLUENCE-nomogram can support in estimating an objective estimate of each individual patient’s risk. Springer US 2022-03-13 2022 /pmc/articles/PMC9090881/ /pubmed/35279762 http://dx.doi.org/10.1007/s10549-022-06549-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Preclinical Study
Ankersmid, Jet W.
Spronk, Pauline E. R.
Zeillemaker, Anneke M.
Siesling, Sabine
Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title_full Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title_fullStr Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title_full_unstemmed Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title_short Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
title_sort health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty
topic Preclinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9090881/
https://www.ncbi.nlm.nih.gov/pubmed/35279762
http://dx.doi.org/10.1007/s10549-022-06549-9
work_keys_str_mv AT ankersmidjetw healthcareprofessionalsoverestimatetheriskforlocoregionalrecurrencesafterbreastcancertreatmentdependingontheirspecialty
AT spronkpaulineer healthcareprofessionalsoverestimatetheriskforlocoregionalrecurrencesafterbreastcancertreatmentdependingontheirspecialty
AT zeillemakerannekem healthcareprofessionalsoverestimatetheriskforlocoregionalrecurrencesafterbreastcancertreatmentdependingontheirspecialty
AT sieslingsabine healthcareprofessionalsoverestimatetheriskforlocoregionalrecurrencesafterbreastcancertreatmentdependingontheirspecialty